NVNovartis NVS · NYSE
$161.47 +0.23% (+$0.37)
- Market cap
- $304.2B
- Enterprise value
- $345.6B
- P/E
- 23.8x
- Forward P/E
- 17.8x
- PEG
- 1.2x
- P/S
- 5.5x
- P/FCF
- 19.2x
- EV/EBITDA
- 15.5x
- ROIC
- 13.9%
- Gross margin
- 74.4%
- Net margin
- 22.9%
- Dividend yield
- 2.94%
- Payout ratio
- 70.2%
- Net debt/EBITDA
- 1.9x
- Beta
- 0.42
- Free float
- 96.9%
About the company
Novartis AG is a Swiss global pharmaceutical company with a broad portfolio of medicines and healthcare products. The company is one of the leading players in the pharmaceutical industry and operates worldwide. Novartis focuses on the development, manufacturing, and distribution of innovative medicines in various therapeutic areas, including oncology, cardiology, ophthalmology, neurology, and others. The company also specializes in the production and sale of generic drugs. Novartis dedicates significant efforts to research and development of new treatment options to help improve the quality of life for patients around the world. The company actively collaborates with medical professionals and institutions to ensure the best care for patients. Novartis AG (NVS) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in a reputable company with a rich medical portfolio and a long history of innovation.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vasant Narasimhan
Employees
75,267
Headquarters
Basel
Valuation
Is today's price reasonable?
- What speaks for it: The share price is below the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 31% a year over the last 3 years.
- What to watch: Earnings per share swing sharply from year to year.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 23 USD is left as net profit.
- What speaks for it: It earns 14 USD a year on every 100 USD of invested capital.
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number